Dr. Smiths Biotech Private Limited, a under cirp private limited company, was established on 24 April 2015 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24246PN2015PTC154818. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.20 Cr.
It upholds a compliant status. Employing 22 professional, Its leadership includes Suraj Shriniwas Zanwar (Director), Prakashchandra Rathi (Director), Riyaz Bashir Khan (Director). Past directors included Kavita Suraj Zanvar, Santosh Pimparkar Shivaji, Prakashchandra Rathi. It holds ₹16.87 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Office No. 508-511, Sacred World, 5Th Floor, Above Macdonald, Vitthal Rao Shivarkar Road, W, Anowrie,, Pune, Maharashtra, 411040.
U24246PN2015PTC154818
154818
24 April 2015
₹2.50 Cr
₹2.20 Cr
Roc Pune
Unlisted
Under Cirp
Explore comprehensive insights into Dr. Smiths Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suraj Shriniwas Zanwar | Director | 24 Apr 2015 | Current |
| Prakashchandra Rathi | Director | 11 Sep 2021 | Current |
| Riyaz Bashir Khan | Director | 03 Jun 2019 | Current |
| Megha Agrawal | Irp/Rp/Liquidator | 23 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 24 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dr. Smiths Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.8% increase. The company also saw a substantial improvement in profitability, with a 129.24% increase in profit. The company's net worth Soared by an impressive increase of 35.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dr. Smiths Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹168,705,998.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2022 | Hdfc Bank Limited | ₹0.71 M | Open |
| 31 Jan 2017 | Sidbi | ₹2.00 Cr | Open |
| 31 Jan 2017 | Sidbi | ₹14.80 Cr | Open |
Explore comprehensive loan charge details -
Dr. Smiths Biotech has a workforce of 22 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dr. Smiths Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Smiths Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Megha Agrawal was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 23 May 2025 & has been associated with this company since 6 months 8 days . was completed.
Progress on Dr. Smiths Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Dr. Smiths Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100583479 was registered on 18 Feb 2022. was completed.
Prakashchandra Rathi was appointed as a Director was appointed as a Director on 11 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
The activity Riyaz Bashir Khan was appointed as a Director was appointed as a Director on 03 Jun 2019 & has been associated with this company since 6 years 5 months . was completed.
The CIN of Dr. Smiths Biotech Private Limited is U24246PN2015PTC154818.
Dr. Smiths Biotech Private Limited is headquartered at Office No. 508-511, Sacred World, 5Th Floor, Above Macdonald, Vitthal Rao Shivarkar Road, W, Anowrie,, Pune, Maharashtra, 411040.
Dr. Smiths Biotech Private Limited was incorporated on 24 April 2015.
The current directors of Dr. Smiths Biotech Private Limited are
The primary industry of Dr. Smiths Biotech Private Limited is Manufacturing.
Dr. Smiths Biotech Private Limited is unlisted.
The authorized capital of Dr. Smiths Biotech Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.20 Cr.
The compliance status of Dr. Smiths Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX